Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates

Omega Therapeutics, Inc. (OMGA) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this company would post a loss of $0.38 per share when it actually produced a loss of $0.36, delivering a surprise of 5.26%. Over the last four quarters, the company ha ...